The impact of influenza virus infection in pregnancy

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 72(14), 978–980 (1919).
  Google Scholar
• 2 Nuzum JW, Pilot I, Stangl FH, Bonar BE. 1918 pandemic influenza and pneumonia in a large civil hospital. IMJ Ill Med. J. 150(6), 612–616 (1976).
  Medline CASGoogle Scholar
• 3 Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am. J. Obstet. Gynecol. 78, 1172–1175 (1959).
  Medline CASGoogle Scholar
• 4 Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect. Dis. 8(1), 44–52 (2008).
  MedlineGoogle Scholar
• 5 Eickhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated with epidemic influenza. JAMA 176, 776–782 (1961).
  Medline CASGoogle Scholar
• 6 Hewagama S, Walker SP, Stuart RL et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin. Infect. Dis. 50(5), 686–690 (2010).
  MedlineGoogle Scholar
• 7 van Kerkhove MD, Vandemaele KAH, Shinde V et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 8(7), e1001053 (2011).
  MedlineGoogle Scholar
• 8 Siston AM, Rasmussen SA, Honein MA et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 303(15), 1517–1525 (2010).
  Medline CASGoogle Scholar
• 9 Louie JK, Acosta M, Jamieson DJ, Honein MA, California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N. Engl. J. Med. 362(1), 27–35 (2010).
  Medline CASGoogle Scholar
• 10 Hartert TV, Neuzil KM, Shintani AK et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am. J. Obstet. Gynecol. 189(6), 1705–1712 (2003).
  MedlineGoogle Scholar
• 11 ANZIC Influenza Investigators, Webb SA, Pettila V et al. Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. N. Engl. J. Med. 361(20), 1925–1934 (2009).
  MedlineGoogle Scholar
• 12 ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ 340, c1279–c1279 (2010).
  MedlineGoogle Scholar
• 13 Yamada T, Yamada T, Morikawa M et al. Pandemic (H1N1) 2009 in pregnant Japanese women in Hokkaido. J. Obstet. Gynaecol. Res. 38(1), 130–136 (2012).
  MedlineGoogle Scholar
• 14 Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 374(9688), 451–458 (2009).
  MedlineGoogle Scholar
• 15 Creanga AA, Johnson TF, Graitcer SB et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet. Gynecol. 115(4), 717–726 (2010).
  MedlineGoogle Scholar
• 16 Callaghan WM, Creanga AA, Jamieson DJ. Pregnancy-related mortality resulting from influenza in the United States During the 2009–2010 pandemic. Obstet. Gynecol. 126(3), 486–490 (2015).
  MedlineGoogle Scholar
• 17 Liu S, Sha J, Yu Z et al. Avian influenza virus in pregnancy. Rev. Med. Virol. 26(4), 268–284 (2016).
  Medline CASGoogle Scholar
• 18 Rein JL, Etra AM, Patel JJ et al. Death of woman with peripartum influenza B virus infection and necrotizing pneumonia. Emerging Infect. Dis. 20(7), 1258–1260 (2014).
  MedlineGoogle Scholar
• 19 Kok J, Blyth CC, Foo H et al. Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus. PLoS ONE 8(2), e55631 (2013).
  Medline CASGoogle Scholar
• 20 Elkus R, Popovich J. Respiratory physiology in pregnancy. Clin. Chest Med. 13(4), 555–565 (1992).
  Medline CASGoogle Scholar
• 21 Ramsey PS, Ramin KD. Pneumonia in pregnancy. Obstet. Gynecol. Clin. North Am. 28(3), 553–569 (2001).
  Medline CASGoogle Scholar
• 22 Yeomans ER, Gilstrap LC. Physiologic changes in pregnancy and their impact on critical care. Crit. Care Med. 33(Suppl. 10), S256–S258 (2005).
  MedlineGoogle Scholar
• 23 Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit. Care Med. 33(10 Suppl), S390–S397 (2005).
  MedlineGoogle Scholar
• 24 Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin. Perinatol. 24(1), 11–14 (2000).
  Medline CASGoogle Scholar
• 25 Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg. Infect. Dis. 12(11), 1638–1643 (2006).
  MedlineGoogle Scholar
• 26 Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int. Rev. Immunol. 21(6), 471–495 (2002).
  Medline CASGoogle Scholar
• 27 Varner MW. Autoimmune disorders and pregnancy. Semin. Perinatol. 15(3), 238–250 (1991).
  Medline CASGoogle Scholar
• 28 Carvalheiras G, Vita P, Marta S et al. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin. Rev. Allergy Immunol. 38(2–3), 302–306 (2010).
  MedlineGoogle Scholar
• 29 Mellor AL, Munn DH. Immunology at the maternal–fetal interface: lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 18(1), 367–391 (2000).
  Medline CASGoogle Scholar
• 30 Kay AW, Bayless NL, Fukuyama J et al. Pregnancy does not attenuate the antibody or plasmablast response to inactivated influenza vaccine. J. Infect. Dis. 212(6), 861–870 (2015). •• Valuable work adding to our understanding of immunology of pregnancy.
  Medline CASGoogle Scholar
• 31 Cérbulo-Vázquez A, Figueroa-Damián R, Arriaga-Pizano LA et al. Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines. PLoS ONE 9(9), e107900 (2014).
  MedlineGoogle Scholar
• 32 Osterholm MT. Preparing for the next pandemic. N. Engl. J. Med. 352(18), 1839–1842 (2005).
  Medline CASGoogle Scholar
• 33 Gordon CL, Johnson PDR, Permezel M et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin. Infect. Dis. 50(5), 672–678 (2010).
  Medline CASGoogle Scholar
• 34 Chan JF-W, To KK-W, Tse H et al. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin. Vaccine Immunol. 18(2), 305–310 (2011).
  Medline CASGoogle Scholar
• 35 Irving WL, James DK, Stephenson T et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 107(10), 1282–1289 (2000).
  Medline CASGoogle Scholar
• 36 Håberg SE, Trogstad L, Gunnes N et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N. Engl. J. Med. 368(4), 333–340 (2013).
  MedlineGoogle Scholar
• 37 Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am. J. Obstet. Gynecol. 205(1), 10–18 (2011).
  MedlineGoogle Scholar
• 38 Centers for Disease Control and Prevention (CDC). Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1) – United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep. 60(35), 1193–1196 (2011).
  MedlineGoogle Scholar
• 39 McNeil SA, Dodds LA, Fell DB et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am. J. Obstet. Gynecol. 204(Suppl. 1), S54–S57 (2011).
  MedlineGoogle Scholar
• 40 Luteijn JM, Brown MJ, Dolk H. Influenza and congenital anomalies: a systematic review and meta-analysis. Hum. Reprod. 29(4), 809–823 (2014).
  Medline CASGoogle Scholar
• 41 Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 16(2), 216–219 (2005).
  MedlineGoogle Scholar
• 42 Edwards MJ. Review: hyperthermia and fever during pregnancy. Birth Defects Res. A Clin. Mol. Teratol. 76(7), 507–516 (2006).
  Medline CASGoogle Scholar
• 43 Kwit K, Pomorska-Mól M, Markowska-Daniel I. Pregnancy outcome and clinical status of gilts following experimental infection by H1N2, H3N2 and H1N1pdm09 influenza A viruses during the last month of gestation. Arch. Virol. 160(10), 2415–2425 (2015).
  Medline CASGoogle Scholar
• 44 Kwit K, Pomorska-Mól M, Markowska-Daniel I. The influence of experimental infection of gilts with swine H1N2 influenza A virus during the second month of gestation on the course of pregnancy, reproduction parameters and clinical status. BMC Vet. Res. 10(1), 123 (2014).
  MedlineGoogle Scholar
• 45 Shi L, Tu N, Patterson PH. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int. J. Dev. Neurosci. 23(2–3), 299–305 (2005).
  MedlineGoogle Scholar
• 46 Paquette SG, Banner D, Huang SSH et al. Influenza transmission in the mother–infant dyad leads to severe disease, mammary gland infection, and pathogenesis by regulating host responses. PLoS Pathog. 11(10), e1005173 (2015).
  MedlineGoogle Scholar
• 47 Engels G, Hierweger AM, Hoffmann J et al. Pregnancy-related immune adaptation promotes the emergence of highly virulent H1N1 influenza virus strains in allogenically pregnant mice. Cell Host Microbe. 21(3), 321–333 (2017).
  Medline CASGoogle Scholar
• 48 Mertz D, Geraci J, Winkup J, Gessner BD, Ortiz JR, Loeb M. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 35(4), 521–528 (2017). •• Meta-analysis showing no increase in mortality or severe outcomes in pregnant women with influenza which contrasts other data and highlights need for further good quality studies.
  MedlineGoogle Scholar
• 49 Anselmi A, Ruggieri VG, Letheulle J et al. Extracorporeal membrane oxygenation in pregnancy. J. Card. Surg. 30(10), 781–786 (2015).
  MedlineGoogle Scholar
• 50 Hui DS, Lee N, Chan PKS. Clinical management of pandemic 2009 influenza A(H1N1) infection. Chest 137(4), 916–925 (2010).
  MedlineGoogle Scholar
• 51 Kusznierz G, Carolina C, Manuel RJ et al. Impact of influenza in the post-pandemic phase: clinical features in hospitalized patients with influenza A (H1N1) pdm09 and H3N2 viruses, during 2013 in Santa Fe, Argentina. J Med. Virol. 89(7), 1186–1191 (2017).
  MedlineGoogle Scholar
• 52 Bonmarin I, Belchior E, Bergounioux J et al. Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons. Euro Surveill. 20(46), 30066 (2015).
  Google Scholar
• 53 Kwok KO, Riley S, Perera RAPM et al. Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1. BMC Infect Dis. 17(1), 337 (2017).
  MedlineGoogle Scholar
• 54 Fiore AE, Fry A, Shay D et al. Antiviral agents for the treatment and chemoprophylaxis of influenza – recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 60(1), 1–24 (2011).
  MedlineGoogle Scholar
• 55 Webster RG, Govorkova EA. Continuing challenges in influenza. Ann. NY Acad. Sci. 1323(1), 115–139 (2014).
  Medline CASGoogle Scholar
• 56 Michiels B, van Puyenbroeck K, Verhoeven V, Vermeire E, Coenen S. The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews. PLoS ONE 8(4), e60348 (2013).
  Medline CASGoogle Scholar
• 57 Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 348, g2545–g2545 (2014).
  MedlineGoogle Scholar
• 58 Hayden FG. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir. Viruses 7(Suppl. 3), 36–43 (2013).
  MedlineGoogle Scholar
• 59 Muthuri SG, Venkatesan S, Myles PR et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir. Med. 2(5), 395–404 (2014).
  Medline CASGoogle Scholar
• 60 Saito S, Minakami H, Nakai A, Unno N, Kubo T, Yoshimura Y. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009. Am. J. Obstet. Gynecol. 209(2), 130.e1–130.e9 (2013).
  CASGoogle Scholar
• 61 Hurt AC, Hardie K, Wilson NJ et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J. Infect. Dis. 206(2), 148–157 (2012).
  Medline CASGoogle Scholar
• 62 Hurt AC, Chotpitayasunondh T, Cox NJ et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect. Dis. 12(3), 240–248 (2012).
  MedlineGoogle Scholar
• 63 Takashita E, Ejima M, Itoh R et al. A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013. Euro Surveill. 19(1), pii:0666 (2014).
  MedlineGoogle Scholar
• 64 Yuen CYS, Tarrant M. Determinants of uptake of influenza vaccination among pregnant women – a systematic review. Vaccine 32(36), 4602–4613 (2014).
  MedlineGoogle Scholar
• 65 The Australian Immunisation Handbook (10th Edition). www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook/10-home.
  Google Scholar
• 66 Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 influenza season. MMWR Morb. Mortal. Wkly. Rep. 64(30), 818–825 (2015).
  MedlineGoogle Scholar
• 67 Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum. Vaccin. Immunother. 8(1), 81–88 (2012).
  MedlineGoogle Scholar
• 68 Jennings Z, Carter I, McPhie K, Kok J, Dwyer DE. Increased prevalence of influenza B/Victoria lineage viruses during early stages of the 2015 influenza season in New South Wales, Australia: implications for vaccination and planning. Euro Surveill. 20(31), pii:21201 (2015).
  MedlineGoogle Scholar
• 69 Hirve S, Lambach P, Paget J, Vandemaele K, Fitzner J, Zhang W. Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review. Influenza Other Respir. Viruses. 10(4), 254–267 (2016). •• Valuable paper highlighting large number of countries without National Influenza Immunization Guidelines.
  MedlineGoogle Scholar
• 70 Thompson MG, Li D-K, Shifflett P et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 and 2011–2012 influenza seasons. Clin. Infect. Dis. 58(4), 449–457 (2014).
  MedlineGoogle Scholar
• 71 Regan AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: a retrospective cohort study. Vaccine 34(32), 3649–3656 (2016).
  MedlineGoogle Scholar
• 72 Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med. 359(15), 1555–1564 (2008). •• One of the only randomized-controlled trials available and showed significant benefit of maternal vaccination for infants <6 months old in whom vaccination is contraindicated.
  Medline CASGoogle Scholar
• 73 Tapia MD, Sow SO, Tamboura B et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised Phase IV trial. Lancet Infect. Dis. 16(9), 1026–1035 (2016).
  MedlineGoogle Scholar
• 74 Steinhoff MC, Katz J, Englund JA et al. Year-round influenza immunisation during pregnancy in Nepal: a Phase IV, randomised, placebo-controlled trial. Lancet Infect. Dis. 17(9), 981–989 (2017).
  MedlineGoogle Scholar
• 75 Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin. Infect. Dis. 51(12), 1355–1361 (2010).
  MedlineGoogle Scholar
• 76 Ding H, Black CL, Ball S et al. Influenza vaccination coverage among pregnant women – United States, 2014–15 influenza season. MMWR Morb Mortal Wkly Rep. 64(36), 1000–1005 (2015).
  MedlineGoogle Scholar
• 77 Public Health England. Surveillance of influenza and other respiratory viruses in the United Kingdom: Winter 2014–2015. www.gov.uk/government/uploads_attachment_data/file429617/Annualreport_March2015_ver4.pdf.
  Google Scholar
• 78 Maher L, Dawson A, Wiley K et al. Influenza vaccination during pregnancy: a qualitative study of the knowledge, attitudes, beliefs, and practices of general practitioners in central and south-western Sydney. BMC Fam. Pract. 15(1), 102 (2014).
  MedlineGoogle Scholar
• 79 Baum U, Leino T, Gissler M, Kilpi T, Jokinen J. Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: a cohort study of pregnancies stratified by trimester of vaccination. Vaccine 33(38), 4850–4857 (2015).
  MedlineGoogle Scholar
• 80 McHugh L, Andrews RM, Lambert SB et al. Birth outcomes for Australian mother–infant pairs who received an influenza vaccine during pregnancy, 2012–2014: The FluMum Study. Vaccine 35(10), 1403–1409 (2017).
  MedlineGoogle Scholar
• 81 Pasternak B, Svanström H, Mølgaard-Nielsen D et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 308(2), 165–174 (2012).
  Medline CASGoogle Scholar
• 82 Zerbo O, Modaressi S, Chan B et al. No association between influenza vaccination during pregnancy and adverse birth outcomes. Vaccine 35(24), 3186–3190 (2017). • Important paper highlighting the safety of maternal influenza vaccination.
  MedlineGoogle Scholar
• 83 Naleway AL, Irving SA, Henninger ML et al. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine 32(26), 3122–3127 (2014).
  MedlineGoogle Scholar
• 84 Regan AK, Moore HC, de Klerk N et al. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin. Infect. Dis. 62(10), 1221–1227 (2016).
  MedlineGoogle Scholar
• 85 Fell DB, Platt RW, Lanes A et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 122(1), 17–26 (2015).
  Medline CASGoogle Scholar
• 86 Sheffield JS, Greer LG, Rogers VL et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet. Gynecol. 120(3), 532–537 (2012).
  MedlineGoogle Scholar
• 87 Ludvigsson JF, Ström P, Lundholm C et al. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ 351, h5585 (2015).
  MedlineGoogle Scholar
• 88 Madhi SA, Cutland CL, Kuwanda L et al. Influenza vaccination of pregnant women and protection of their infants. N. Engl. J. Med. 371(10), 918–931 (2014).
  MedlineGoogle Scholar
• 89 Kay AW, Blish CA. Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Front. Immunol. 6, 289 (2015).
  MedlineGoogle Scholar